mutLBSgeneDB |
Gene summary for FNTA |
Gene summary |
Basic gene Info. | Gene symbol | FNTA |
Gene name | farnesyltransferase, CAAX box, alpha | |
Synonyms | FPTA|PGGT1A|PTAR2 | |
Cytomap | UCSC genome browser: 8p11 | |
Type of gene | protein-coding | |
RefGenes | NM_002027.2, NR_033698.1,NM_001018676.1,NM_001018677.1, | |
Description | FTase-alphaGGTase-I-alphafarnesyl-protein transferase alpha-subunitprotein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaprotein prenyltransferase alpha subunit repeat containing 2ras proteins prenyltransferase subunit alphatype | |
Modification date | 20141207 | |
dbXrefs | MIM : 134635 | |
HGNC : HGNC | ||
Ensembl : ENSG00000168522 | ||
HPRD : 00607 | ||
Vega : OTTHUMG00000165279 | ||
Protein | UniProt: P49354 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_FNTA | |
BioGPS: 2339 | ||
Pathway | NCI Pathway Interaction Database: FNTA | |
KEGG: FNTA | ||
REACTOME: FNTA | ||
Pathway Commons: FNTA | ||
Context | iHOP: FNTA | |
ligand binding site mutation search in PubMed: FNTA | ||
UCL Cancer Institute: FNTA | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0018343 | protein farnesylation | 16893176 | GO:0018344 | protein geranylgeranylation | 16893176 | GO:0090044 | positive regulation of tubulin deacetylation | 19228685 | GO:0090045 | positive regulation of deacetylase activity | 19228685 |
Top |
Ligand binding site mutations for FNTA |
Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.) : non-synonymous mutation on LBS, Circle size denotes number of samples. |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | N165 | N165K | COAD | 1 | Q167 | W169C | GBM | 1 | H201 | W203L | UCEC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for FNTA |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | N165 | N165K | -1.5019117 | Q167 | W169C | -0.67697721 | H201 | W203L | -0.52231278 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for FNTA from PDB |
Top |
Differential gene expression and gene-gene network for FNTA |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for FNTA |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for FNTA |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Gene-centered drug-gene interaction network |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Investigational | DB04893 | AZD3409 | Small molecule | |
Experimental | DB06953 | 2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE | Small molecule | |
Experimental | DB07216 | (11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE | Small molecule | |
Experimental | DB07227 | 4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE | Small molecule | |
Experimental | DB07771 | [(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID | Small molecule | |
Experimental | DB07780 | FARNESYL DIPHOSPHATE | Small molecule | |
Experimental | DB07841 | GERANYLGERANYL DIPHOSPHATE | Small molecule | |
Experimental | DB07895 | ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID | Small molecule | |
Experimental | DB08180 | 2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE | Small molecule | |
Experimental | DB08674 | (20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE | Small molecule | |
Experimental | DB08676 | (20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE | Small molecule |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of FNTA go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | FPP | FARNESYL DIPHOSPHATE | 2f0y | A | H201 | FII | FPP ANALOG | 2iej | A | H201 | S48 | METHYL N-{(3S)-1-[(1-METHYL-1H-IMIDAZOL-5-YL)METHYL]-6-PHENYL-1,2,3,4-TETRAHYDROQUINOLIN-3-YL}-N-[(1-METHYL-1H-IMIDAZOL-4-YL)SULFONYL]GLYCINATE | 2iej | A | N165 | III | Peptide ligand (ASP,ASP,PRO,THR,ALA,SER,ALA,CYS,ASN,ILE,GLN) | 1tn6 | A | Q167 | III | Peptide ligand (CYS,VAL,LEU,SER) | 2h6f | A | Q167 | III | Peptide ligand (CYS,VAL,LEU,SER) | 2h6g | A | Q167 | III | Peptide ligand (PRO,THR,ALA,SER,ALA,CYS,VAL,LEU,SER) | 2h6h | A | Q167 | III | Peptide ligand (CYS,VAL,LEU,SER) | 2h6i | A | Q167 | 739 | 2(S)-{2(S)-[2(R)-AMINO-3-MERCAPTO]PROPYLAMINO-3(S)-METHYL}PENTYLOXY-3-PHENYLPROPIONYLMETHIONINE SULFONE | 1jcq | A | Q167 H201 |
Top |
Conservation information for LBS of FNTA |
Multiple alignments for P49354 in multiple species |
LBS | AA sequence | # species | Species | H201 | DAKNYHAWQHR | 4 | Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus | H201 | DSKNYHVWSYR | 2 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c), Schizosaccharomyces pombe (strain 972 / ATCC 24843) | H201 | DAKHYHAWSHR | 1 | Arabidopsis thaliana | K164 | IEEQPKNYQVW | 4 | Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus | K164 | AEDNSKNYQLW | 1 | Arabidopsis thaliana | K164 | TLNNPKNYQIW | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | K164 | AEDFQKNYQVW | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | N165 | EEQPKNYQVWH | 4 | Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus | N165 | EDNSKNYQLWH | 1 | Arabidopsis thaliana | N165 | LNNPKNYQIWS | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | N165 | EDFQKNYQVWH | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | Q167 | QPKNYQVWHHR | 4 | Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus | Q167 | NSKNYQLWHHR | 1 | Arabidopsis thaliana | Q167 | NPKNYQIWSYR | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | Q167 | FQKNYQVWHHR | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | Y131 | LNAANYTVWHF | 4 | Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus | Y131 | LNSGNYTVWHF | 1 | Arabidopsis thaliana | Y131 | VAPAFYTIWNY | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | Y131 | NNPAHYTVWAY | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | Y166 | EQPKNYQVWHH | 4 | Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus | Y166 | DNSKNYQLWHH | 1 | Arabidopsis thaliana | Y166 | NNPKNYQIWSY | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | Y166 | DFQKNYQVWHH | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | Y200 | QDAKNYHAWQH | 4 | Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus | Y200 | LDAKHYHAWSH | 1 | Arabidopsis thaliana | Y200 | DDSKNYHVWSY | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | Y200 | IDSKNYHVWSY | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |